Zacks Investment Research on MSN
Cardinal Health, Inc. (CAH) Soars to 52-Week High, Time to Cash Out?
Shares have been on the move with the stock up 29.4% over the past month. The stock hit a new 52-week high of $210.33 in the previous session. Cardinal has gained 77.1% since the start of the year ...
Dublin-based wholesale drug distribution and medical supplies company Cardinal Health is spending $3.9 billion on two acquisitions.
Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...
Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Cardinal Health (CAH) one of those stocks right now? A quick ...
Cardinal Health is building another warehouse in central Ohio as the wholesale drug distribution and medical supply company builds out capacity for the distribution for over-the-counter consumer ...
Cardinal Health shared its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology ...
Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...
The COVID-19 pandemic exposed critical flaws in hospital supply chains for vital equipment like ventilators and personal protective gear. Many health systems struggled with shortages and often ...
Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion. Updates with ...
Cardinal Health has no plans to sell its medical supply division despite ongoing struggles, this time due to inflation, CEO Mike Kaufmann said. Here's how Cardinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results